{"created_at":"Fri Jan 23 06:11:30 +0000 2015","id":558507296301789186,"id_str":"558507296301789186","text":"RT @ScripDonnaDC: ICYMI: Novartis adds another Cosentyx approval with FDA nod \nhttp:\/\/t.co\/wGsJNUNdrP  \n$NVS #Cosentyx #FDA #secukinumab #p\u2026","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":21079030,"id_str":"21079030","name":"SCRIP Intelligence","screen_name":"scripnews","location":"Global","url":"http:\/\/www.scripintelligence.com","description":"The final word in pharmaceutical intelligence.","protected":false,"verified":false,"followers_count":13427,"friends_count":269,"listed_count":376,"favourites_count":65,"statuses_count":18192,"created_at":"Tue Feb 17 10:33:29 +0000 2009","utc_offset":0,"time_zone":"London","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/378800000165182001\/Ls3y30LV.jpeg","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/378800000165182001\/Ls3y30LV.jpeg","profile_background_tile":false,"profile_link_color":"D90B34","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"FADCE1","profile_text_color":"0F0E0F","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2158690990\/Scrip_Intelligence_twitter_128_128_normal.jpg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2158690990\/Scrip_Intelligence_twitter_128_128_normal.jpg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Thu Jan 22 15:53:29 +0000 2015","id":558291369492746240,"id_str":"558291369492746240","text":"ICYMI: Novartis adds another Cosentyx approval with FDA nod \nhttp:\/\/t.co\/wGsJNUNdrP  \n$NVS #Cosentyx #FDA #secukinumab #psoriasis","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":593813785,"id_str":"593813785","name":"Donna Young","screen_name":"ScripDonnaDC","location":"Washington","url":"http:\/\/scripintelligence.com\/capitolcapsule\/","description":"Washington Editor for Scrip Intelligence","protected":false,"verified":false,"followers_count":2493,"friends_count":1634,"listed_count":115,"favourites_count":62,"statuses_count":20141,"created_at":"Tue May 29 15:45:45 +0000 2012","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/828264930\/6cd70d5efa13824b51e8f8dbd73a36c3.jpeg","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/828264930\/6cd70d5efa13824b51e8f8dbd73a36c3.jpeg","profile_background_tile":true,"profile_link_color":"0084B4","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/474939099648778240\/Ug76s07w_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/474939099648778240\/Ug76s07w_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/593813785\/1402071031","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":2,"favorite_count":0,"entities":{"hashtags":[{"text":"Cosentyx","indices":[91,100]},{"text":"FDA","indices":[101,105]},{"text":"secukinumab","indices":[106,118]},{"text":"psoriasis","indices":[119,129]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/wGsJNUNdrP","expanded_url":"http:\/\/bit.ly\/1JabG8U","display_url":"bit.ly\/1JabG8U","indices":[61,83]}],"user_mentions":[],"symbols":[{"text":"NVS","indices":[86,90]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"Cosentyx","indices":[109,118]},{"text":"FDA","indices":[119,123]},{"text":"secukinumab","indices":[124,136]},{"text":"psoriasis","indices":[137,140]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/wGsJNUNdrP","expanded_url":"http:\/\/bit.ly\/1JabG8U","display_url":"bit.ly\/1JabG8U","indices":[79,101]}],"user_mentions":[{"screen_name":"ScripDonnaDC","name":"Donna Young","id":593813785,"id_str":"593813785","indices":[3,16]}],"symbols":[{"text":"NVS","indices":[104,108]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1421993490659"}
{"created_at":"Fri Jan 23 13:41:04 +0000 2015","id":558620433483059200,"id_str":"558620433483059200","text":"$ARRY $NVS:\n\nArray Biopharma (ARRY) to Acquire encorafenib Rights from Novartis:\n\nhttp:\/\/t.co\/QpYDZVBHUI","source":"\u003ca href=\"http:\/\/www.stocknewswires.com\" rel=\"nofollow\"\u003eStockNewsWires\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2341445778,"id_str":"2341445778","name":"StockNewsWires","screen_name":"StockNewsWires","location":"United States","url":null,"description":"Invest like a fish","protected":false,"verified":false,"followers_count":125,"friends_count":9,"listed_count":16,"favourites_count":0,"statuses_count":37923,"created_at":"Thu Feb 13 05:31:52 +0000 2014","utc_offset":-14400,"time_zone":"Atlantic Time (Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C6E2EE","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme2\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme2\/bg.gif","profile_background_tile":false,"profile_link_color":"1F98C7","profile_sidebar_border_color":"C6E2EE","profile_sidebar_fill_color":"DAECF4","profile_text_color":"663B12","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/542238326397227008\/UfZ0ulTf_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/542238326397227008\/UfZ0ulTf_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/QpYDZVBHUI","expanded_url":"http:\/\/www.stocknewswires.com\/2015\/01\/arry-nvs-array-biopharma-arry-to-acquire-encorafenib-rights-from-novartis.html","display_url":"stocknewswires.com\/2015\/01\/arry-n\u2026","indices":[82,104]}],"user_mentions":[],"symbols":[{"text":"ARRY","indices":[0,5]},{"text":"NVS","indices":[6,10]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1422020464665"}
